---
schema_version: "secwatch.filing_event.v1"
accession: "0000075252-23-000022"
form_type: "8-K"
ticker: "ACH"
cik: "0000075252"
company_name: "ACCENDRA HEALTH INC/VA/"
filed_at: "2023-05-05T23:59:59+00:00"
generated_at: "2026-06-15T18:39:58.121497+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Owens & Minor posts Q1 net loss $(0.32)/share; raises 2023 guidance on Patient Direct strength

## Summary
- Revenue $2.5B (+4.8% YoY); GAAP net loss $24.4M vs. net income $39.3M in Q1 2022.
- Adjusted EPS $0.05 vs. $0.96 prior year; adjusted operating income $47.7M vs. $104.9M.
- Patient Direct segment drove margin expansion; Products & Healthcare Services saw destocking pressure.
- Raised 2023 guidance: revenue $10.35-10.55B, adjusted EBITDA $480-510M (from $465-490M).
- Generated $158M operating cash flow; paid down $117M debt in Q1.

## SEC filing metadata
- accession: 0000075252-23-000022
- form_type: 8-K
- ticker: ACH
- cik: 0000075252
- company_name: ACCENDRA HEALTH INC/VA/
- filed_at: 2023-05-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/75252/000007525223000022/0000075252-23-000022-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/75252/000007525223000022/omi-20230505.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000075252-23-000022
- JSON: https://secwatch.observer/filing/0000075252-23-000022.json
- Plain text: https://secwatch.observer/filing/0000075252-23-000022.txt

## Key facts
- Earnings Releases
  ACCENDRA HEALTH INC/VA/ reported the first quarter ended March 31, 2023 results: revenue $2,523, net income $(24.4), EPS $(0.32). Guidance raised.
  - Period: the first quarter ended March 31, 2023
  - Revenue: $2,523
  - Net income: $(24.4)
  - EPS: $(0.32)
  - Guidance: raised
  - Result: reported results
  source text: Financial Summary (1) ($ in millions, except per share data) 1Q23 1Q22 Revenue $2,523 $2,407 Operating income, GAAP $9.8 $61.1 Adj. Operating Income, Non-GAAP $47.7 $104.9 Net (loss) income, GAAP $(24.4) $39.3 Adj. Net Income, Non-GAAP $3.6 $72.8 Adj. EBITDA, Non-GAAP $108.7 $122.6 Net (loss) income per common share, GAAP $(0.32) $0.52 Adj. Net Income per share, Non-GAAP $0.05 $0.96
  evidence_url: https://www.sec.gov/Archives/edgar/data/75252/000007525223000022/0000075252-23-000022-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.